AIM
BCAB icon

Arcadia Investment Management’s BioAtla BCAB Stock Holding History

Arcadia Investment Management’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-28
Closed -$797 – 367
2025
Q4 		$797 Hold
28
– – ﹤0.01% 285
2025
Q3 		$966 Hold
28
– – ﹤0.01% 249
2025
Q2 		$556 Hold
28
– – ﹤0.01% 249
2025
Q1 		$487 Hold
28
– – ﹤0.01% 267
2024
Q4 		$830 Buy
+28
New +$2.35K ﹤0.01% 300

Other funds holding BCAB

ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Arcadia Investment Management's BCAB Position: Q1 2026 in Review

Arcadia Investment Management sold out of BioAtla (BCAB) in Q1 2026, closing a stake of 28 shares — an estimated $797 sold.

Arcadia Investment Management first reported a position in BCAB in Q4 2024 and held it in 5 quarters. The position peaked at $966 in Q3 2025. 36 funds tracked by Wall St. Rank hold BCAB as of Q1 2026.

  • Arcadia Investment Management reported no remaining BioAtla position as of Q1 2026 after selling out during the quarter.
  • Arcadia Investment Management sold 28 BioAtla shares in Q1 2026, an estimated $797.
  • Arcadia Investment Management first reported a position in BioAtla in Q4 2024 and held it in 5 quarters.
  • Arcadia Investment Management's BioAtla position peaked at $966 in Q3 2025.
  • 36 funds tracked by Wall St. Rank held BioAtla as of Q1 2026.

Based on Arcadia Investment Management's 13F filing for Q1 2026, filed 22 Apr 2026.